156953 Marketing to the marginalized: Tobacco industry targeting of the homeless, mentally ill, and injection drug users

Monday, November 5, 2007: 9:45 PM

Dorie E. Apollonio, PhD , Clinical Pharmacy, University of California, San Francisco, San Francisco, CA
Ruth Malone, RN, PhD, FAAN , Social and Behavioral Sciences, University of California, San Francisco, San Francisco, CA
Objectives. Describe the tobacco industry's relationships with and influence on homeless, mentally ill, and injection drug using smokers, and organizations providing services to them. Methods. We analyze internal tobacco industry documents and journal articles. Results. The tobacco industry has marketed cigarettes to the homeless, seriously mentally ill, and recovering injection drug users, part of its "downscale" market, and has developed relationships with homeless shelters, treatment centers, and advocacy groups for these populations, gaining positive media coverage and political support. Discussion. Tobacco control advocates and public health organizations should consider how to target programs to marginalized individuals. Education of service providers about tobacco industry efforts to cultivate this market may help in reducing smoking in these populations.

Learning Objectives:
1. Recognize tobacco industry efforts to (a) recruit smokers in marginalized populations that have not been previously studied and (b) form alliances with organizations that provide services to marginalized populations 2. List two cases where service organizations funded by the tobacco industry were recruited to advocate for tobacco industry policy priorities 3. Develop interventions and policies that reduce smoking prevalence in marginalized populations

Keywords: Tobacco Control, Underserved Populations

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.